Bright Minds Biosciences Inc (DRUG) — Financial Flexibility Index
Bright Minds Biosciences Inc (DRUG) has a Financial Flexibility Index of -3.64x as of December 2025. Free cash flow of $-5.82 Million (operating CF $-5.82 Million minus capex $0.00) represents -4% of total liabilities ($1.60 Million). Also explore net asset momentum of Bright Minds Biosciences Inc to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bright Minds Biosciences Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Bright Minds Biosciences Inc across 7 annual periods. Check strategic asset allocation of Bright Minds Biosciences Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Bright Minds Biosciences Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Bright Minds Biosciences Inc. For the full company profile including market capitalisation, see DRUG market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.66x | $-8.69 Million | $-8.69 Million | $2.38 Million | ▼ -12.3% |
| 2024 | -3.26x | $-1.85 Million | $-1.85 Million | $568.26K | ▲ +87.0% |
| 2023 | -25.01x | $-7.02 Million | $-7.02 Million | $280.86K | ▼ -184.3% |
| 2022 | -8.80x | $-13.59 Million | $-13.59 Million | $1.54 Million | ▲ +23.2% |
| 2021 | -11.46x | $-7.32 Million | $-7.32 Million | $638.57K | ▼ -499.8% |
| 2020 | -1.91x | $-288.39K | $-288.39K | $150.92K | ▼ -67.0% |
| 2019 | -1.14x | $-42.01K | $-42.01K | $36.71K | — |